Skip to content
Governance Register

← US public companies

TNF Pharmaceuticals, Inc.

SEC CIK 1321834 · TNFA · last insider filing 2026-05-14

Directors (from insider filings)

NameCapacity as filedFilings
Voss Chelsea Sierra Director filed 2026 - 2026
Silverman Joshua Director · Executive Chairman filed 2018 - 2026
White Billy Joe Director filed 2018 - 2026
Bernstein Bruce Director filed 2025 - 2026
Glass Mitchell Director · President, CMO filed 2024 - 2026
Friscia Stephen Director filed 2024 - 2026
Chapman Christopher C JR Director · President, Chief Med. Officer filed 2021 - 2023
Eagle Craig Director filed 2021 - 2023
Schreiber Christopher C Director · Executive Chairman filed 2018 - 2023
Uzonwanne Jude Director filed 2021 - 2023
Schroeder Robert C Director filed 2019 - 2021
Tarbox Richard C III Director filed 2018 - 2018
Gormally John J Director · Chief Executive Officer filed 2015 - 2018
Knox Brandon Thomas Director filed 2014 - 2017
Akers Raymond Francis JR Director · Executive Chairman, Secretary filed 2014 - 2016
Knox Thomas J Director filed 2014 - 2016
Andrews Robert E Director filed 2015 - 2015
Bokhari Raza Director filed 2015 - 2015
Moran Gavin Director filed 2014 - 2015
Nicolette Thomas Albert Director · CEO and President filed 2014 - 2014

Officers (from insider filings)

NameTitle as filedFilings
Rauch Gary M VP of Finance, Treasurer filed 2014 - 2025
Rhodes IAN Thomas Interim CFO filed 2021 - 2025
Rivard Paul EVP of Operations, GC filed 2021 - 2023
Kaplin Adam Chief Scientific Officer filed 2021 - 2023
Benson Stuart M Chief Financial Officer filed 2020 - 2020
Yeaton Howard CEO, CFO filed 2018 - 2019

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.